Free Trial Information
BioCentury | Oct 9, 2020
Deals

Oct. 8 Quick Takes: Kronos ready for NASDAQ debut; plus Sensei, TCRyption, Jazz, Pfizer-Opko and Moderna

...the technology could be applied to vaccines for COVID-19 and other infectious diseases. BC Staff Kronos Bio Pfizer Opko Sensei Biotherapeutics Empresas La Moderna S.A. TCRyption...
Read More
BioCentury | Jan 6, 2014
Company News

Gruenenthal, Empresas Andromaco Group deal

...in cash, or CLP152.1 billion ($288.2 million). Gruenenthal said it acquired all subsidiaries of the Empresas...
...chairman and former majority shareholder of Laboratorios Andromaco, kept a "significant" stake in Laboratorios Andromaco. Empresas...
...the acquisition complements its business and therapeutic areas in the Andean countries and Central America. Empresas...
Read More
BioCentury | Nov 12, 2012
Company News

Empresa Brasileira de Hemoderivados e Biotecnologia (Hemobras), Baxter sales and marketing update

Brazilian state company Hemobras granted Baxter the exclusive right to become Brazil's provider of recombinant factor VIII ( rFVIII ) to treat hemophilia A over the next 20 years. Baxter will receive payments for the product supplied...
Read More
BioCentury | Sep 22, 2008
Finance

Shaking in their shorts

Shaking in their shortsA handful of heavily shorted small cap biotechs got a bounce last week after the U.S. Securities and Exchange Commission announced new actions intended to eliminate "naked" short selling - the abusive practice...
Read More
BioCentury | Aug 14, 2000
Company News

Dow AgroSciences, Empresa Brasileira de Sementes deal

Dow Agro acquired Empresa Brasileira, which breeds, develops, produces and sells corn and grain sorghum seeds in Brazil. Dow Agro said it will use Empresa’s capabilities to develop tropical corn germplasm. Dow AgroSciences LLC , Indianapolis,...
Read More
BioCentury | Sep 8, 1998
Company News

DNAP, Empresas La Moderna S.A. de C.V. deal

...at $3.375 on Friday, has 18.8 million shares outstanding. DNAP Holding Corp. (DNAP), Oakland, Calif. Empresas La Moderna S.A....
Read More
BioCentury | Jul 27, 1998
Company News

DNAP, Empresas La Moderna S.A. de C.V. deal

...$4.125 on Friday, has 18.8 million common shares outstanding. DNAP Holding Corp. (DNAP), Oakland, Calif. Empresas La Moderna S.A....
Read More
BioCentury | Jul 6, 1998
Company News

Empresas La Moderna S.A. de C.V. deal

...position in Nath Sluis Ltd. (Munbai, India), an agbio company, for $1.5 million in cash. Empresas La Moderna S.A....
Read More
BioCentury | Mar 9, 1998
Politics, Policy & Law

BIO's letter to DNAP

...is still at the company. DNA Plant Technology Corp. was merged into a unit of Empresas...
Read More
BioCentury | Jan 12, 1998
Politics, Policy & Law

Tobacco science and other embarrassments

...the alleged events happened before the company was merged into the fresh produce unit of Empresas...
Read More
Items per page:
1 - 10 of 17
BioCentury | Oct 9, 2020
Deals

Oct. 8 Quick Takes: Kronos ready for NASDAQ debut; plus Sensei, TCRyption, Jazz, Pfizer-Opko and Moderna

...the technology could be applied to vaccines for COVID-19 and other infectious diseases. BC Staff Kronos Bio Pfizer Opko Sensei Biotherapeutics Empresas La Moderna S.A. TCRyption...
Read More
BioCentury | Jan 6, 2014
Company News

Gruenenthal, Empresas Andromaco Group deal

...in cash, or CLP152.1 billion ($288.2 million). Gruenenthal said it acquired all subsidiaries of the Empresas...
...chairman and former majority shareholder of Laboratorios Andromaco, kept a "significant" stake in Laboratorios Andromaco. Empresas...
...the acquisition complements its business and therapeutic areas in the Andean countries and Central America. Empresas...
Read More
BioCentury | Nov 12, 2012
Company News

Empresa Brasileira de Hemoderivados e Biotecnologia (Hemobras), Baxter sales and marketing update

Brazilian state company Hemobras granted Baxter the exclusive right to become Brazil's provider of recombinant factor VIII ( rFVIII ) to treat hemophilia A over the next 20 years. Baxter will receive payments for the product supplied...
Read More
BioCentury | Sep 22, 2008
Finance

Shaking in their shorts

Shaking in their shortsA handful of heavily shorted small cap biotechs got a bounce last week after the U.S. Securities and Exchange Commission announced new actions intended to eliminate "naked" short selling - the abusive practice...
Read More
BioCentury | Aug 14, 2000
Company News

Dow AgroSciences, Empresa Brasileira de Sementes deal

Dow Agro acquired Empresa Brasileira, which breeds, develops, produces and sells corn and grain sorghum seeds in Brazil. Dow Agro said it will use Empresa’s capabilities to develop tropical corn germplasm. Dow AgroSciences LLC , Indianapolis,...
Read More
BioCentury | Sep 8, 1998
Company News

DNAP, Empresas La Moderna S.A. de C.V. deal

...at $3.375 on Friday, has 18.8 million shares outstanding. DNAP Holding Corp. (DNAP), Oakland, Calif. Empresas La Moderna S.A....
Read More
BioCentury | Jul 27, 1998
Company News

DNAP, Empresas La Moderna S.A. de C.V. deal

...$4.125 on Friday, has 18.8 million common shares outstanding. DNAP Holding Corp. (DNAP), Oakland, Calif. Empresas La Moderna S.A....
Read More
BioCentury | Jul 6, 1998
Company News

Empresas La Moderna S.A. de C.V. deal

...position in Nath Sluis Ltd. (Munbai, India), an agbio company, for $1.5 million in cash. Empresas La Moderna S.A....
Read More
BioCentury | Mar 9, 1998
Politics, Policy & Law

BIO's letter to DNAP

...is still at the company. DNA Plant Technology Corp. was merged into a unit of Empresas...
Read More
BioCentury | Jan 12, 1998
Politics, Policy & Law

Tobacco science and other embarrassments

...the alleged events happened before the company was merged into the fresh produce unit of Empresas...
Read More
Items per page:
1 - 10 of 17